Co-Authors
This is a "connection" page, showing publications co-authored by Fengcai Zhu and Xiangxi Wang.
Connection Strength
0.458
-
Structure-based development of human antibody cocktails against SARS-CoV-2. Cell Res. 2021 01; 31(1):101-103.
Score: 0.229
-
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021 02; 21(2):181-192.
Score: 0.228